Exact Mass: 377.13689780000004

Imidaprilat

(4S)-1-Methyl-3-{(2S)-2-[N-((1S)-1-carboxy-3-phenylpropyl)amino]propionyl}-2-oxo-imidazolidine-4-carboxylic acid

Imidaprilat, is the active metabolite of Imidapril. Imidapril is a prodrug used to treat hypertension, chronic congestive heart failure (CHF), acute myocardial infarction (AMI), and diabetic nephropathy (PMID: 17547476,18192036,12177688, 17094051). Imidapril belongs to a class of long-acting, non-sulfhydryl angiotensin-converting enzyme (ACE) inhibitors (PMID: 8851752, 12177688). Imidaprilat competitively binds and inhibits the catalytic activity of ACE, which results in a reduction of peripheral resistance and a reduction in systemic blood pressure (BP) (PMID: 17547476). Imidaprilat is only found in individuals that have used or taken imidapril. D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors > D000806 - Angiotensin-Converting Enzyme Inhibitors C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent C471 - Enzyme Inhibitor > C783 - Protease Inhibitor > C247 - ACE Inhibitor

8-Amino-8-demethylriboflavin

C19H13F2N7 (377.12004420000005)

JNJ-38877605

C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C164000 - c-Met-targeting Agent C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor

Reduced haloperidol

4-(4-(4-Chlorophenyl)-4-hydroxy-1-piperidinyl)-1-(4-fluorophenyl)-1-butanol

Reduced haloperidol is a metabolite of haloperidol. Haloperidol is a typical antipsychotic. It is in the butyrophenone class of antipsychotic medications and has pharmacological effects similar to the phenothiazines. Haloperidol is an older antipsychotic used in the treatment of schizophrenia and acute psychotic states and delirium. (Wikipedia)

Kinetin-7-N-glucoside

(2R,3R,4S,5S,6R)-2-(6-{[(furan-2-yl)methyl]amino}-7H-purin-7-yl)-6-(hydroxymethyl)oxane-3,4,5-triol

Kinetin-7-N-glucoside belongs to the class of organic compounds known as glycosylamines. Glycosylamines are compounds consisting of an amine with a beta-N-glycosidic bond to a carbohydrate, thus forming a cyclic hemiaminal ether bond (alpha-amino ether). Kinetin-7-N-glucoside is a strong basic compound (based on its pKa). Kinetin-7-N-glucoside is the product of the reaction between kinetin and UDP-D-glucose, with UDP as a co-product. The reaction is catalyzed by a UDP glycosyltransferase. Kinetin-7-N-glucoside is the product of the reaction between kinetin and UDP-D-glucose, with UDP as a co-product. The reaction is catalyzed by a UDP glycosyltransferase. [HMDB]

Kinetin-9-N-glucoside

(2R,3R,4S,5S,6R)-2-(6-{[(furan-2-yl)methyl]amino}-9H-purin-9-yl)-6-(hydroxymethyl)oxane-3,4,5-triol

Kinetin-9-N-glucoside belongs to the class of organic compounds known as glycosylamines. Glycosylamines are compounds consisting of an amine with a beta-N-glycosidic bond to a carbohydrate, thus forming a cyclic hemiaminal ether bond (alpha-amino ether). Kinetin-9-N-glucoside is a strong basic compound (based on its pKa). Kinetin-9-N-glucoside is the product of the reaction between kinetin and UDP-D-glucose, with UDP as a co-product. The reaction is catalyzed by a UDP glycosyltransferase.

7-[(3S,4S)-3-(Benzenesulfonamido)-2-bicyclo[2.2.1]heptanyl]hept-5-enoic acid

7-[(3S,4S)-3-(Benzenesulphonamido)-2-bicyclo[2.2.1]heptanyl]hept-5-enoic acid

3-(2-(N-(1-Carboxy-3-phenylpropyl)amino)propionyl)-1-methyl-2-oxoimidazolidine-4-carboxylic acid

D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors > D000806 - Angiotensin-Converting Enzyme Inhibitors

S-(2-Hydroxy-3-buten-1-yl)glutathione

2-Amino-5-[[1-(carboxymethylamino)-3-(2-hydroxybut-3-enylsulfanyl)-1-oxopropan-2-yl]amino]-5-oxopentanoic acid

4-(4-Fluorophenyl)-2-(4-methylsulfinylphenyl)-5-(4-pyridyl)-1H-imidazole

4-[4-(4-fluorophenyl)-2-(4-methanesulfinylphenyl)-1H-imidazol-5-yl]pyridine

C18H20FN3O5 (377.13869220000004)

7H-Pyrido(1,2,3-de)-1,4-benzoxazine-6-carboxylic acid, 9-fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-, N-oxide

11-carboxy-7-fluoro-2-methyl-6-(4-methylpiperazin-1-yl)-10-oxo-4-oxa-1-azatricyclo[7.3.1.0^{5,13}]trideca-5(13),6,8,11-tetraen-1-ium-1-olate

D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D024841 - Fluoroquinolones

Methyl 4-(2-(2-hydroxy-2-(3-chlorophenyl)ethylamino)propyl)phenoxyacetate

Methyl 2-[4-(2-{[2-(3-chlorophenyl)-2-hydroxyethyl]amino}propyl)phenoxy]acetic acid

D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D000322 - Adrenergic Agonists

(2S)-2-(Butanoylamino)-5-[[(1R)-2-(carboxymethylamino)-2-oxo-1-(sulfanylmethyl)ethyl]amino]-5-oxo-pentanoic acid

(2S)-2-(Butanoylamino)-5-[[(1R)-2-(carboxymethylamino)-2-oxo-1-(sulphanylmethyl)ethyl]amino]-5-oxo-pentanoic acid

3-[2-(4-Fluorophenyl)ethylamino]-1-methyl-4-(2-methyl-1H-indol-3-yl)pyrrole-2,5-dione

3-{[2-(4-fluorophenyl)ethyl]amino}-1-methyl-4-(2-methyl-1H-indol-3-yl)-2,5-dihydro-1H-pyrrole-2,5-dione

N-Hbgd

6-({[4-(hydroxymethyl)phenyl]methyl}[sulphanyl(carbonothioyl)]amino)hexane-1,2,3,4,5-pentol

C15H23NO6S2 (377.0966738)

Sulfinalol

4-(1-Hydroxy-2-{[4-(4-methoxyphenyl)butan-2-yl]amino}ethyl)-2-methanesulphinylphenol

Talarozole

N-{4-[2-ethyl-1-(1H-1,2,4-triazol-1-yl)butyl]phenyl}-1,3-benzothiazol-2-amine

C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C274 - Antineoplastic Agent > C129818 - Antineoplastic Hormonal/Endocrine Agent > C481 - Antiestrogen C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C1740 - Aromatase Inhibitor D004791 - Enzyme Inhibitors > D065607 - Cytochrome P-450 Enzyme Inhibitors C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor C147908 - Hormone Therapy Agent > C547 - Hormone Antagonist

(3E,6Z)-3-Benzylidene-6-[[4-[2-(dimethylamino)ethoxy]phenyl]methylidene]piperazine-2,5-dione

Lasmiditan

2,4,6-trifluoro-N-(6-((1-Methylpiperidin-4-yl)carbonyl)pyridin-2yl)benzamide

C19H18F3N3O2 (377.1351044)

N - Nervous system > N02 - Analgesics > N02C - Antimigraine preparations > N02CC - Selective serotonin (5ht1) agonists D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D017366 - Serotonin Receptor Agonists C78272 - Agent Affecting Nervous System > C47794 - Serotonin Agonist

Ethoxysanguinarine

23-ethoxy-24-methyl-5,7,18,20-tetraoxa-24-azahexacyclo[11.11.0.0^{2,10.0^{4,8.0^{14,22.0^{17,21]tetracosa-1(13),2,4(8),9,11,14(22),15,17(21)-octaene

C20H24NO4+.Cl- (377.13937740000006)

Ethoxysanguinarine is a benzophenanthridine alkaloid natural product that is mainly found in Macleaya cordata. Ethoxysanguinarine is an inhibitor of protein phosphatase 2A (CIP2A). Ethoxysanguinarine induces cell apoptosis and inhibits colorectal cancer cells growth[1]. Ethoxysanguinarine is a benzophenanthridine alkaloid natural product that is mainly found in Macleaya cordata. Ethoxysanguinarine is an inhibitor of protein phosphatase 2A (CIP2A). Ethoxysanguinarine induces cell apoptosis and inhibits colorectal cancer cells growth[1].

Phellodendrine HCl

6H-Dibenzo[a,g]quinolizinium,5,8,13,13a-tetrahydro-2,11-dihydroxy-3,10-dimethoxy-7-methyl-, chloride (1:1),(7S,13aS)-

Phellodendrine chloride is a plant alkaloid found in Phellodendron amurense. Phellodendrine chloride suppresses the proliferation of KRAS mutated pancreatic cancer cells through inhibition of nutrients uptake via macropinocytosis [1]. Phellodendrine chloride promotes autophagy by regulating the AMPK/mTOR pathway and reduce the intestinal damage of ulcerative colitis[2]. Phellodendrine chloride is a plant alkaloid found in Phellodendron amurense. Phellodendrine chloride suppresses the proliferation of KRAS mutated pancreatic cancer cells through inhibition of nutrients uptake via macropinocytosis [1]. Phellodendrine chloride promotes autophagy by regulating the AMPK/mTOR pathway and reduce the intestinal damage of ulcerative colitis[2].

Phellodendrine

(13aS)-2,11-dihydroxy-3,10-dimethoxy-7-methyl-5,6,7,8,13,13a-hexahydroisoquinolino[3,2-a]isoquinolin-7-ium chloride

C20H24NO4+.Cl- (377.13937740000006)

Piscerythoxazole

7-Hydroxy-5-methoxy-2-prenyloxazol[2,3:4,3]isoflavone

Neoamphimedine Z

cycloatalaphylline A

Leuconicine F

FMOC-DL-2-furylalanine

FT-0666151

Maybridge1_000863

5-Fluoro-NPB-22

Oprea1_555258

UNII-K9H6459WGA

C24H21F2NO (377.159112)

Oprea1_066506

C27H23NO (377.1779548)

S-4-(2-oxo-butyl)glutathione

GNF-Pf-2361

L-gamma-glutamyl-S-3-(1-oxobutyl)-L-cysteinyl-glycine

This record was created by the financial support of MEXT/JSPS KAKENHI Grant Number 16HP2005 to the Mass Spectrometry Society of Japan.

O1-(2-acetylamino-[1]naphthyl)-beta-D-glucopyranuronic acid|O1-(2-Acetylamino-[1]naphthyl)-beta-D-glucopyranuronsaeure

C18H19NO8 (377.1110614)

4-methoxyfuro[2,3-b]quinolin-7-yl beta-D-mannopyranoside|dictamnine-7-beta-D-mannopyranoside

C18H19NO8 (377.1110614)

SCHEMBL21148869

C15H27N3O8 (377.1798062)

(-)-circumdatin J|(S)-(-)-circumdatin J|(S)-2,12-dimethoxy-5b,6,7,8-tetrahydrobenzo[6,7]pyrrolo[2,1:3,4][1,4]diazepino[2,1-b]quinazoline-10,16-dione|circumdatin J

(2-hydroxy-1-methoxy-12-methyl-12,13-dihydro-[1,3]dioxolo[4,5:4,5]benzo[1,2-c]phenanthridin-13-yl)-acetaldehyde|11-(Formyl-methylenyl)-O-desmethyl-dihydrochelerythrin

6-methoxy-11,12,13,14,14a,15-hexahydro-9H-benzo[h][1,3]dioxolo[4,5:4,5]benzo[1,2-f]pyrido[1,2-b]isoquinolin-12-ol|Cryptopleuridin|Cryptopleuridine

Salviamine D

waltherione A

C19H23NO7

pyrrolemarumine 4-O-alpha-L-rhamnopyranoside

bruceolline K

An indole alkaloid that is 1,2,3,4-tetrahydrocyclopenta[b]indole substituted by geminal-methyl groups at position 3, an oxo group at position 1 and a beta-D-glucopyranosyloxy group at position 2.It has been isolated from the ethanol extract of the stems of Brucea mollis.

O1-(6-acetylamino-[2]naphthyl)-beta-D-glucopyranuronic acid|O1-(6-Acetylamino-[2]naphthyl)-beta-D-glucopyranuronsaeure

C18H19NO8 (377.1110614)

aureonitrile

16-Methoxycarbonyl-18,19-dihydroxynaufoline

14-Ethoxy-13-methyl-13,14-dihydro-[1,3]dioxolo[4,5:4,5]benzo[1,2-c][1,3]dioxolo[4,5-i]phenanthridine

SCHEMBL14175700

Euxylophoricine D

Cys Leu Glu

cysteylglutaminyllysine

Glu Val Met

Leu Cys Glu

Asp Asp Glu

Asp Met Ile

Val Glu Met

Glu Cys Leu

Gln Cys Gln

Ile Asp Met

Val Met Glu

Glu Met Val

Pro Met Met

Cys Gln Gln

Asp Ile Met

Pro Asp Phe

Ile Met Asp

Met Val Glu

Asp Pro Phe

Glu Asp Asp

Leu Glu Cys

SB 203580

4-[4-(4-fluorophenyl)-2-[4-methylsulfinyl)phenyl]-1H-imidazol-5-yl]-pyridine

D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics D000893 - Anti-Inflammatory Agents D018501 - Antirheumatic Agents C308 - Immunotherapeutic Agent D004791 - Enzyme Inhibitors

Phe Pro Asp

Glu Glu Thr

Lys Cys Gln

Met Pro Met

Met Ile Asp

Pro Phe Asp

Met Asp Ile

Cys Lys Gln

Met Glu Val

Thr Glu Glu

Cissamine chloride

3,10-dimethoxy-7-methyl-6,8,13,13a-tetrahydro-5H-isoquinolino[2,1-b]isoquinolin-7-ium-2,9-diol;chloride

Cyclanoline (chloride) shows cholinesterase inhibitory activity[1].

Escholine chloride

(6aS)-2,10-dimethoxy-6,6-dimethyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinolin-6-ium-1,11-diol;chloride

Magnoflorine chloride (Magnoflorine chloride), an aporphine alkaloid found in Magnolia or Aristolochia, reduces the formation of C. albicans biofilm[1]. Magnoflorine chloride has anti-fungal, anti-antidiabetic and anti-oxidative activity[2]. Magnoflorine chloride (Magnoflorine chloride), an aporphine alkaloid found in Magnolia or Aristolochia, reduces the formation of C. albicans biofilm[1]. Magnoflorine chloride has anti-fungal, anti-antidiabetic and anti-oxidative activity[2].

Phellodendrine HCl

(13aS)-2,11-dihydroxy-3,10-dimethoxy-7-methyl-5,6,7,8,13,13a-hexahydroisoquinolino[3,2-a]isoquinolin-7-ium chloride

Phentolamine mesilate

Phentolamine mesylate (Phentolamine methanesulfonate) is a reversible, non-selective, and orally active blocker of α1 and α2 adrenergic receptor that expands blood vessels to reduce peripheral vascular resistance. Phentolamine mesylate can be used for the research of pheochromocytoma-related hypertension, heart failure and erectile dysfunction[1][2][3].

Naltrexone HCl

Naltrexone Hydrochloride

Polanrazine B_120170

C18H23N3O2S2 (377.1231618)

MMV084603

Hydroxyhaloperidol

Abyssomicin B

Ala Ala Cys Asn

(2S)-2-[(2R)-2-[(2S)-2-[(2S)-2-aminopropanamido]propanamido]-3-sulfanylpropanamido]-3-carbamoylpropanoic acid

Ala Ala Asn Cys

(2R)-2-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]propanamido]-3-carbamoylpropanamido]-3-sulfanylpropanoic acid

Ala Cys Ala Asn

(2S)-2-[(2S)-2-[(2R)-2-[(2S)-2-aminopropanamido]-3-sulfanylpropanamido]propanamido]-3-carbamoylpropanoic acid

Ala Cys Gly Lys

(2S)-6-amino-2-{2-[(2R)-2-[(2S)-2-aminopropanamido]-3-sulfanylpropanamido]acetamido}hexanoic acid

Ala Cys Gly Gln

(2S)-2-{2-[(2R)-2-[(2S)-2-aminopropanamido]-3-sulfanylpropanamido]acetamido}-4-carbamoylbutanoic acid

Ala Cys Lys Gly

2-[(2S)-6-amino-2-[(2R)-2-[(2S)-2-aminopropanamido]-3-sulfanylpropanamido]hexanamido]acetic acid

Ala Cys Asn Ala

(2S)-2-[(2S)-2-[(2R)-2-[(2S)-2-aminopropanamido]-3-sulfanylpropanamido]-3-carbamoylpropanamido]propanoic acid

Ala Cys Gln Gly

2-[(2S)-2-[(2R)-2-[(2S)-2-aminopropanamido]-3-sulfanylpropanamido]-4-carbamoylbutanamido]acetic acid

Ala Gly Cys Lys

(2S)-6-amino-2-[(2R)-2-{2-[(2S)-2-aminopropanamido]acetamido}-3-sulfanylpropanamido]hexanoic acid

Ala Gly Cys Gln

(2S)-2-[(2R)-2-{2-[(2S)-2-aminopropanamido]acetamido}-3-sulfanylpropanamido]-4-carbamoylbutanoic acid

Ala Gly Lys Cys

(2R)-2-[(2S)-6-amino-2-{2-[(2S)-2-aminopropanamido]acetamido}hexanamido]-3-sulfanylpropanoic acid

Ala Gly Gln Cys

(2R)-2-[(2S)-2-{2-[(2S)-2-aminopropanamido]acetamido}-4-carbamoylbutanamido]-3-sulfanylpropanoic acid

Ala Lys Cys Gly

2-[(2R)-2-[(2S)-6-amino-2-[(2S)-2-aminopropanamido]hexanamido]-3-sulfanylpropanamido]acetic acid

Ala Lys Gly Cys

(2R)-2-{2-[(2S)-6-amino-2-[(2S)-2-aminopropanamido]hexanamido]acetamido}-3-sulfanylpropanoic acid

Ala Asn Ala Cys

(2R)-2-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-3-carbamoylpropanamido]propanamido]-3-sulfanylpropanoic acid

Ala Asn Cys Ala

(2S)-2-[(2R)-2-[(2S)-2-[(2S)-2-aminopropanamido]-3-carbamoylpropanamido]-3-sulfanylpropanamido]propanoic acid

Ala Asn Ser Ser

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-3-carbamoylpropanamido]-3-hydroxypropanamido]-3-hydroxypropanoic acid

Ala Gln Cys Gly

2-[(2R)-2-[(2S)-2-[(2S)-2-aminopropanamido]-4-carbamoylbutanamido]-3-sulfanylpropanamido]acetic acid

Ala Gln Gly Cys

(2R)-2-{2-[(2S)-2-[(2S)-2-aminopropanamido]-4-carbamoylbutanamido]acetamido}-3-sulfanylpropanoic acid

Ala Ser Asn Ser

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-3-hydroxypropanamido]-3-carbamoylpropanamido]-3-hydroxypropanoic acid

Ala Ser Ser Asn

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-3-hydroxypropanamido]-3-hydroxypropanamido]-3-carbamoylpropanoic acid

Cys Ala Ala Asn

(2S)-2-[(2S)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]propanamido]propanamido]-3-carbamoylpropanoic acid

Cys Ala Gly Lys

(2S)-6-amino-2-{2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]propanamido]acetamido}hexanoic acid

Cys Ala Gly Gln

(2S)-2-{2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]propanamido]acetamido}-4-carbamoylbutanoic acid

Cys Ala Lys Gly

2-[(2S)-6-amino-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]propanamido]hexanamido]acetic acid

Cys Ala Asn Ala

(2S)-2-[(2S)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]propanamido]-3-carbamoylpropanamido]propanoic acid

Cys Ala Gln Gly

2-[(2S)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]propanamido]-4-carbamoylbutanamido]acetic acid

Cys Gly Ala Lys

(2S)-6-amino-2-[(2S)-2-{2-[(2R)-2-amino-3-sulfanylpropanamido]acetamido}propanamido]hexanoic acid

Cys Gly Ala Gln

(2S)-2-[(2S)-2-{2-[(2R)-2-amino-3-sulfanylpropanamido]acetamido}propanamido]-4-carbamoylbutanoic acid

Cys Gly Lys Ala

(2S)-2-[(2S)-6-amino-2-{2-[(2R)-2-amino-3-sulfanylpropanamido]acetamido}hexanamido]propanoic acid

Cys Gly Gln Ala

(2S)-2-[(2S)-2-{2-[(2R)-2-amino-3-sulfanylpropanamido]acetamido}-4-carbamoylbutanamido]propanoic acid

Cys Lys Ala Gly

2-[(2S)-2-[(2S)-6-amino-2-[(2R)-2-amino-3-sulfanylpropanamido]hexanamido]propanamido]acetic acid

Cys Lys Gly Ala

(2S)-2-{2-[(2S)-6-amino-2-[(2R)-2-amino-3-sulfanylpropanamido]hexanamido]acetamido}propanoic acid

Cys Asn Ala Ala

(2S)-2-[(2S)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-carbamoylpropanamido]propanamido]propanoic acid

Cys Gln Ala Gly

2-[(2S)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-4-carbamoylbutanamido]propanamido]acetic acid

Cys Gln Gly Ala

(2S)-2-{2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-4-carbamoylbutanamido]acetamido}propanoic acid

Gly Ala Cys Lys

(2S)-6-amino-2-[(2R)-2-[(2S)-2-(2-aminoacetamido)propanamido]-3-sulfanylpropanamido]hexanoic acid

Gly Ala Cys Gln

(2S)-2-[(2R)-2-[(2S)-2-(2-aminoacetamido)propanamido]-3-sulfanylpropanamido]-4-carbamoylbutanoic acid

Gly Ala Lys Cys

(2R)-2-[(2S)-6-amino-2-[(2S)-2-(2-aminoacetamido)propanamido]hexanamido]-3-sulfanylpropanoic acid

Gly Ala Gln Cys

(2R)-2-[(2S)-2-[(2S)-2-(2-aminoacetamido)propanamido]-4-carbamoylbutanamido]-3-sulfanylpropanoic acid

Gly Cys Ala Lys

(2S)-6-amino-2-[(2S)-2-[(2R)-2-(2-aminoacetamido)-3-sulfanylpropanamido]propanamido]hexanoic acid

Gly Cys Ala Gln

(2S)-2-[(2S)-2-[(2R)-2-(2-aminoacetamido)-3-sulfanylpropanamido]propanamido]-4-carbamoylbutanoic acid

Gly Cys Lys Ala

(2S)-2-[(2S)-6-amino-2-[(2R)-2-(2-aminoacetamido)-3-sulfanylpropanamido]hexanamido]propanoic acid

Gly Cys Gln Ala

(2S)-2-[(2S)-2-[(2R)-2-(2-aminoacetamido)-3-sulfanylpropanamido]-4-carbamoylbutanamido]propanoic acid

Gly Gly Met Asn

(2S)-2-[(2S)-2-[2-(2-aminoacetamido)acetamido]-4-(methylsulfanyl)butanamido]-3-carbamoylpropanoic acid

Gly Gly Asn Met

(2S)-2-[(2S)-2-[2-(2-aminoacetamido)acetamido]-3-carbamoylpropanamido]-4-(methylsulfanyl)butanoic acid

Gly Lys Ala Cys

(2R)-2-[(2S)-2-[(2S)-6-amino-2-(2-aminoacetamido)hexanamido]propanamido]-3-sulfanylpropanoic acid

Gly Lys Cys Ala

(2S)-2-[(2R)-2-[(2S)-6-amino-2-(2-aminoacetamido)hexanamido]-3-sulfanylpropanamido]propanoic acid

Gly Met Gly Asn

(2S)-2-{2-[(2S)-2-(2-aminoacetamido)-4-(methylsulfanyl)butanamido]acetamido}-3-carbamoylpropanoic acid

Gly Met Asn Gly

2-[(2S)-2-[(2S)-2-(2-aminoacetamido)-4-(methylsulfanyl)butanamido]-3-carbamoylpropanamido]acetic acid

Gly Asn Gly Met

(2S)-2-{2-[(2S)-2-(2-aminoacetamido)-3-carbamoylpropanamido]acetamido}-4-(methylsulfanyl)butanoic acid

Gly Asn Met Gly

2-[(2S)-2-[(2S)-2-(2-aminoacetamido)-3-carbamoylpropanamido]-4-(methylsulfanyl)butanamido]acetic acid

Gly Asn Ser Thr

(2S,3R)-2-[(2S)-2-[(2S)-2-(2-aminoacetamido)-3-carbamoylpropanamido]-3-hydroxypropanamido]-3-hydroxybutanoic acid

Gly Asn Thr Ser

(2S)-2-[(2S,3R)-2-[(2S)-2-(2-aminoacetamido)-3-carbamoylpropanamido]-3-hydroxybutanamido]-3-hydroxypropanoic acid

Gly Gln Ala Cys

(2R)-2-[(2S)-2-[(2S)-2-(2-aminoacetamido)-4-carbamoylbutanamido]propanamido]-3-sulfanylpropanoic acid

Gly Gln Cys Ala

(2S)-2-[(2R)-2-[(2S)-2-(2-aminoacetamido)-4-carbamoylbutanamido]-3-sulfanylpropanamido]propanoic acid

Gly Gln Ser Ser

(2S)-2-[(2S)-2-[(2S)-2-(2-aminoacetamido)-4-carbamoylbutanamido]-3-hydroxypropanamido]-3-hydroxypropanoic acid

Gly Ser Asn Thr

(2S,3R)-2-[(2S)-2-[(2S)-2-(2-aminoacetamido)-3-hydroxypropanamido]-3-carbamoylpropanamido]-3-hydroxybutanoic acid

Gly Ser Gln Ser

(2S)-2-[(2S)-2-[(2S)-2-(2-aminoacetamido)-3-hydroxypropanamido]-4-carbamoylbutanamido]-3-hydroxypropanoic acid

Gly Ser Ser Gln

(2S)-2-[(2S)-2-[(2S)-2-(2-aminoacetamido)-3-hydroxypropanamido]-3-hydroxypropanamido]-4-carbamoylbutanoic acid

Gly Ser Thr Asn

(2S)-2-[(2S,3R)-2-[(2S)-2-(2-aminoacetamido)-3-hydroxypropanamido]-3-hydroxybutanamido]-3-carbamoylpropanoic acid

Gly Thr Asn Ser

(2S)-2-[(2S)-2-[(2S,3R)-2-(2-aminoacetamido)-3-hydroxybutanamido]-3-carbamoylpropanamido]-3-hydroxypropanoic acid

Gly Thr Ser Asn

(2S)-2-[(2S)-2-[(2S,3R)-2-(2-aminoacetamido)-3-hydroxybutanamido]-3-hydroxypropanamido]-3-carbamoylpropanoic acid

Met Asn Asn

Glu Val Met

C18H20FN3O5 (377.13869220000004)

Levofloxacin N-oxide

Lys Gln Cys

Lys Ala Cys Gly

2-[(2R)-2-[(2S)-2-[(2S)-2,6-diaminohexanamido]propanamido]-3-sulfanylpropanamido]acetic acid

Lys Ala Gly Cys

(2R)-2-{2-[(2S)-2-[(2S)-2,6-diaminohexanamido]propanamido]acetamido}-3-sulfanylpropanoic acid

Lys Cys Ala Gly

2-[(2S)-2-[(2R)-2-[(2S)-2,6-diaminohexanamido]-3-sulfanylpropanamido]propanamido]acetic acid

Lys Cys Gly Ala

(2S)-2-{2-[(2R)-2-[(2S)-2,6-diaminohexanamido]-3-sulfanylpropanamido]acetamido}propanoic acid

Leu Met Asp

Met Ile Asp

Lys Gly Ala Cys

(2R)-2-[(2S)-2-{2-[(2S)-2,6-diaminohexanamido]acetamido}propanamido]-3-sulfanylpropanoic acid

Lys Gly Cys Ala

(2S)-2-[(2R)-2-{2-[(2S)-2,6-diaminohexanamido]acetamido}-3-sulfanylpropanamido]propanoic acid

Asn Met Asn

Cys Gln Gln

Asn Asn Met

Asp Leu Met

Lys Cys Gln

Met Glu Val

Gln Gln Cys

Asp Ile Met

Met Met Pro

Glu Met Val

Met Gly Gly Asn

(2S)-2-(2-{2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]acetamido}acetamido)-3-carbamoylpropanoic acid

Asp Phe Pro

Met Gly Asn Gly

2-[(2S)-2-{2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]acetamido}-3-carbamoylpropanamido]acetic acid

Ile Asp Met

Met Asn Gly Gly

2-{2-[(2S)-2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]-3-carbamoylpropanamido]acetamido}acetic acid

Gln Cys Lys

Asp Met Leu

Glu Thr Glu

Asn Ala Ala Cys

(2R)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]propanamido]propanamido]-3-sulfanylpropanoic acid

Asn Ala Cys Ala

(2S)-2-[(2R)-2-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]propanamido]-3-sulfanylpropanamido]propanoic acid

Phe Asp Pro

Asn Ala Ser Ser

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]propanamido]-3-hydroxypropanamido]-3-hydroxypropanoic acid

Asn Cys Ala Ala

(2S)-2-[(2S)-2-[(2R)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-sulfanylpropanamido]propanamido]propanoic acid

Asn Gly Gly Met

(2S)-2-(2-{2-[(2S)-2-amino-3-carbamoylpropanamido]acetamido}acetamido)-4-(methylsulfanyl)butanoic acid

Asn Gly Met Gly

2-[(2S)-2-{2-[(2S)-2-amino-3-carbamoylpropanamido]acetamido}-4-(methylsulfanyl)butanamido]acetic acid

Asn Gly Ser Thr

(2S,3R)-2-[(2S)-2-{2-[(2S)-2-amino-3-carbamoylpropanamido]acetamido}-3-hydroxypropanamido]-3-hydroxybutanoic acid

Asn Gly Thr Ser

(2S)-2-[(2S,3R)-2-{2-[(2S)-2-amino-3-carbamoylpropanamido]acetamido}-3-hydroxybutanamido]-3-hydroxypropanoic acid

Leu Asp Met

Asn Met Gly Gly

2-{2-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]-4-(methylsulfanyl)butanamido]acetamido}acetic acid

Asn Ser Ala Ser

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-hydroxypropanamido]propanamido]-3-hydroxypropanoic acid

Asn Ser Gly Thr

(2S,3R)-2-{2-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-hydroxypropanamido]acetamido}-3-hydroxybutanoic acid

Asn Ser Ser Ala

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-hydroxypropanamido]-3-hydroxypropanamido]propanoic acid

Asn Ser Thr Gly

2-[(2S,3R)-2-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-hydroxypropanamido]-3-hydroxybutanamido]acetic acid

Asn Thr Gly Ser

(2S)-2-{2-[(2S,3R)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-hydroxybutanamido]acetamido}-3-hydroxypropanoic acid

Asn Thr Ser Gly

2-[(2S)-2-[(2S,3R)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-hydroxybutanamido]-3-hydroxypropanamido]acetic acid

Met Asp Ile

Asp Met Ile

Gln Cys Gln

Cys Lys Gln

Gln Ala Cys Gly

2-[(2R)-2-[(2S)-2-[(2S)-2-amino-4-carbamoylbutanamido]propanamido]-3-sulfanylpropanamido]acetic acid

Gln Ala Gly Cys

(2R)-2-{2-[(2S)-2-[(2S)-2-amino-4-carbamoylbutanamido]propanamido]acetamido}-3-sulfanylpropanoic acid

Gln Cys Ala Gly

2-[(2S)-2-[(2R)-2-[(2S)-2-amino-4-carbamoylbutanamido]-3-sulfanylpropanamido]propanamido]acetic acid

Gln Cys Gly Ala

(2S)-2-{2-[(2R)-2-[(2S)-2-amino-4-carbamoylbutanamido]-3-sulfanylpropanamido]acetamido}propanoic acid

Gln Gly Ala Cys

(2R)-2-[(2S)-2-{2-[(2S)-2-amino-4-carbamoylbutanamido]acetamido}propanamido]-3-sulfanylpropanoic acid

Gln Gly Cys Ala

(2S)-2-[(2R)-2-{2-[(2S)-2-amino-4-carbamoylbutanamido]acetamido}-3-sulfanylpropanamido]propanoic acid

Gln Gly Ser Ser

(2S)-2-[(2S)-2-{2-[(2S)-2-amino-4-carbamoylbutanamido]acetamido}-3-hydroxypropanamido]-3-hydroxypropanoic acid

Cys Gln Lys

Gln Ser Gly Ser

(2S)-2-{2-[(2S)-2-[(2S)-2-amino-4-carbamoylbutanamido]-3-hydroxypropanamido]acetamido}-3-hydroxypropanoic acid

Gln Ser Ser Gly

2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-carbamoylbutanamido]-3-hydroxypropanamido]-3-hydroxypropanamido]acetic acid

Ile Met Asp

Met Leu Asp

Met Asp Leu

Val Glu Met

Val Met Glu

Asp Glu Asp

Ser Ala Asn Ser

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]propanamido]-3-carbamoylpropanamido]-3-hydroxypropanoic acid

Ser Ala Ser Asn

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]propanamido]-3-hydroxypropanamido]-3-carbamoylpropanoic acid

Ser Gly Asn Thr

(2S,3R)-2-[(2S)-2-{2-[(2S)-2-amino-3-hydroxypropanamido]acetamido}-3-carbamoylpropanamido]-3-hydroxybutanoic acid

Ser Gly Gln Ser

(2S)-2-[(2S)-2-{2-[(2S)-2-amino-3-hydroxypropanamido]acetamido}-4-carbamoylbutanamido]-3-hydroxypropanoic acid

Ser Gly Ser Gln

(2S)-2-[(2S)-2-{2-[(2S)-2-amino-3-hydroxypropanamido]acetamido}-3-hydroxypropanamido]-4-carbamoylbutanoic acid

Ser Gly Thr Asn

(2S)-2-[(2S,3R)-2-{2-[(2S)-2-amino-3-hydroxypropanamido]acetamido}-3-hydroxybutanamido]-3-carbamoylpropanoic acid

Ser Asn Ala Ser

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-carbamoylpropanamido]propanamido]-3-hydroxypropanoic acid

Ser Asn Gly Thr

(2S,3R)-2-{2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-carbamoylpropanamido]acetamido}-3-hydroxybutanoic acid

Gln Lys Cys

Ser Asn Ser Ala

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-carbamoylpropanamido]-3-hydroxypropanamido]propanoic acid

Ser Asn Thr Gly

2-[(2S,3R)-2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-carbamoylpropanamido]-3-hydroxybutanamido]acetic acid

Ser Gln Gly Ser

(2S)-2-{2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-4-carbamoylbutanamido]acetamido}-3-hydroxypropanoic acid

Ser Gln Ser Gly

2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-4-carbamoylbutanamido]-3-hydroxypropanamido]acetic acid

Ser Ser Ala Asn

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-hydroxypropanamido]propanamido]-3-carbamoylpropanoic acid

Ser Ser Gly Gln

(2S)-2-{2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-hydroxypropanamido]acetamido}-4-carbamoylbutanoic acid

Ser Ser Asn Ala

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-hydroxypropanamido]-3-carbamoylpropanamido]propanoic acid

Ser Ser Gln Gly

2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-hydroxypropanamido]-4-carbamoylbutanamido]acetic acid

Ser Thr Gly Asn

(2S)-2-{2-[(2S,3R)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-hydroxybutanamido]acetamido}-3-carbamoylpropanoic acid

Ser Thr Asn Gly

2-[(2S)-2-[(2S,3R)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-hydroxybutanamido]-3-carbamoylpropanamido]acetic acid

Met Val Glu

Thr Gly Asn Ser

(2S)-2-[(2S)-2-{2-[(2S,3R)-2-amino-3-hydroxybutanamido]acetamido}-3-carbamoylpropanamido]-3-hydroxypropanoic acid

Thr Gly Ser Asn

(2S)-2-[(2S)-2-{2-[(2S,3R)-2-amino-3-hydroxybutanamido]acetamido}-3-hydroxypropanamido]-3-carbamoylpropanoic acid

Thr Asn Gly Ser

(2S)-2-{2-[(2S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-3-carbamoylpropanamido]acetamido}-3-hydroxypropanoic acid

Thr Asn Ser Gly

2-[(2S)-2-[(2S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-3-carbamoylpropanamido]-3-hydroxypropanamido]acetic acid

Thr Ser Gly Asn

(2S)-2-{2-[(2S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-3-hydroxypropanamido]acetamido}-3-carbamoylpropanoic acid

Thr Ser Asn Gly

2-[(2S)-2-[(2S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-3-hydroxypropanamido]-3-carbamoylpropanamido]acetic acid

Haloperidol (reduced)

4-(4-Chlorophenyl)-a-(4-fluorophenyl)-4-hydroxy-1-piperidinebutanol

Kinetin-7-N-glucoside

Kinetin-9-N-glucoside

Asn-His-OH

(S)-2-(3-(2-amino-2-oxoethoxy)-4-nitrobenzamido)-4-(1H-imidazol-4-yl)butanoic acid

C15H15N5O7 (377.097144)

Imidaprilat

(4S)-3-[(2S)-2-{[(1S)-1-carboxy-3-phenylpropyl]amino}propanoyl]-1-methyl-2-oxoimidazolidine-4-carboxylic acid

A member of the class of imidazolidines that is imidapril in which the ethyl ester group has been hydrolysed to the corresponding acid group. It is the active metabolite of imidapril used to treat hypertension. D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors > D000806 - Angiotensin-Converting Enzyme Inhibitors C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent C471 - Enzyme Inhibitor > C783 - Protease Inhibitor > C247 - ACE Inhibitor

3-[[2-(4-phenylmethoxyphenoxy)acetyl]amino]benzoic acid

C17H19N3O5S (377.10453640000003)

tert-Butyl (triphenylphosphoranylidene)carbamate

C23H24NO2P (377.1544574)

Omeprazole Sulfone N-Oxide

[4-(3-Methoxyphenyl)-1-piperazinyl](5-methyl-3-phenyl-1,2-oxazol- 4-yl)methanone

Risotilide

C16H19N5O4S (377.11576940000003)

disperse blue 124

2-[N-ethyl-4-[(5-nitrothiazol-2-yl)azo]-m-toluidino]ethyl acetate

1,3,3-trimethyl-2-[(methyl-2-naphthylhydrazono)methyl]-3H-indolium chloride

C23H24ClN3 (377.16586540000003)

4-Phenylpiperidine-4-carboxylic acid, compound with toluene-p-sulphonic acid

C19H23NO5S (377.12968680000006)

3-AMINO-3-(3,4-DIBENZYLOXY-PHENYL)-PROPIONIC ACID

Lufuradom

diethyl (6-chloro-2,3,4,9-tetrahydro-1H-carbazol-2-yl)methylmalonate

C19H15N5O4 (377.11239900000004)

Disperse Orange 29

fenetylline hydrochloride

C18H24ClN5O2 (377.1618434)

3-(4-Methoxybenzyloxy)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridinehydrochloride

eddp perchlorate

C26H19NO2 (377.14157140000003)

1-(4-nitrophenyl)-1,2,2-triphenylethylene

Urea, N-cyclopropyl-N-[(1,2-dihydro-6-methyl-2-oxo-3-quinolinyl)methyl]-N-(2-methoxyphenyl)- (9CI)

C17H20ClN5O3 (377.1254600000001)

HG-10-102-01

2-Dodecylisoquinolinium bromide

C21H32BrN (377.1717972)

Fmoc-D-His-OH

Fmoc-D-2-Furylalanine

Fmoc-L-2-Furylalanine

C16H36ClCrNO3 (377.1788676000001)

Tetrabutylammonium chlorochromate

3-Dibenzylamino-2-fluoropropionic acid, benzyl ester

C24H24FNO2 (377.1790976)

2-Carboxy-5-fluoro-1-[(1-naphthalenyl)methyl]-1H-indole-3-acetic acid

C22H16FNO4 (377.1063308)

dibutyl [[(diethylamino)thioxomethyl]thio]succinate

C17H31NO4S2 (377.1694406)

2-BROMO-6-IODO-3-METHOXYPYRIDINE

C22H16FNO4 (377.1063308)

tert-Butyl 2-bromo-3-cyclohexyl-1H-indole-6-carboxylate

C19H24BrNO2 (377.0990304)

Methanone, [4-(4-methoxyphenyl)-1-piperazinyl](5-methyl-3-phenyl-4-isoxazolyl)-

C19H20ClNO5 (377.1029940000001)

Ronifibrate

3-[2-(4-chlorophenoxy)-2-methylpropanoyl]oxypropyl pyridine-3-carboxylate

C78276 - Agent Affecting Digestive System or Metabolism > C29703 - Antilipidemic Agent > C98150 - Fibrate Antilipidemic Agent C - Cardiovascular system > C10 - Lipid modifying agents > C10A - Lipid modifying agents, plain > C10AB - Fibrates

Sulfinalol

C19H18F3N3S (377.11734640000003)

C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C72900 - Adrenergic Antagonist

5-(4-TERT-BUTYLPHENYL)-4-[3-(TRIFLUOROMETHYL)PHENYL]-1,2,4-TRIAZOLE-3-THIOL

Thiocarbanidin

Propafenone hydrochloride

C18H24BNO5S (377.14681640000003)

D002317 - Cardiovascular Agents > D026941 - Sodium Channel Blockers > D061567 - Voltage-Gated Sodium Channel Blockers C78274 - Agent Affecting Cardiovascular System > C47793 - Antiarrhythmic Agent D002317 - Cardiovascular Agents > D000889 - Anti-Arrhythmia Agents D049990 - Membrane Transport Modulators C93038 - Cation Channel Blocker

Paroxol Tosylate

C20H24FNO3S (377.1460846)

(4-(N-Butyl-N-(4-methoxybenzyl)sulfamoyl)phenyl)boronic acid

tert-Butyl 5-chloro-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole-1-carboxylate

tert-Butyl 7-chloro-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole-1-carboxylate

C21H19N3S2 (377.10203340000004)

ERRα antagonist-1

(R)-Talarozole

Talarozole (R enantiomer)

Isocorydine hydrochloride

BENAZEPRIL HCL

1-(3,4-Dimethoxybenzyl)-6,7-dimethoxy-3,4-dihydroisoquinoline hydrochloride

C15H19N7O3S (377.12700240000004)

CH5132799

5-(7-(methylsulfonyl)-2-morpholino-6,7-dihydro-5H-pyrrolo[2,3-d]pyrimidin-4-yl)pyrimidin-2-amine

C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C2152 - Phosphatidylinositide 3-Kinase Inhibitor C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor C274 - Antineoplastic Agent > C1742 - Angiogenesis Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor

Setiptiline maleate

Setiptiline (maleate)

Setiptiline maleate (MO-8282 maleate) is a serotonin receptor antagonist. Setiptiline maleate is a tetracyclic antidepressant (TeCA) which acts as a noradrenergic and specific serotonergic antidepressant (NaSSA). Setiptiline maleate acts as a norepinephrine reuptake inhibitor, α2-adrenergic receptor antagonist, and serotonin receptor antagonist, likely at the 5-HT2A, 5-HT2C, and/or 5-HT3 subtypes, as well as an H1 receptor inverse agonist/antihistamine[1][2][3][4].

Domitroban

7-[(3S,4S)-3-(Benzenesulfonamido)-2-bicyclo[2.2.1]heptanyl]hept-5-enoic acid

D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006727 - Hormone Antagonists > D011448 - Prostaglandin Antagonists C78275 - Agent Affecting Blood or Body Fluid > C29750 - Thrombolytic Agent D006401 - Hematologic Agents > D010975 - Platelet Aggregation Inhibitors

AC-BETA-(2-THIENYL)-ALA-OH

C19H23NO5S (377.12968680000006)

1,2-di-o-acetyl-3-azido-3-deoxy-5-o-toluoyl-d-ribofuranose

C17H19N3O7 (377.1222944)

H-Phe-Oall.TosOH

Apixaban Impurity 12

tert-Butyl 6-chloro-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole-1-carboxylate

C16H19N5O4S (377.11576940000003)

5-ethyl-5,10-dihydro-10,10-diphenylphenosilazine

C26H23NSi (377.1599678)

Selurampanel

C78272 - Agent Affecting Nervous System > C264 - Anticonvulsant Agent

Ethyl 6-fluoro-1-methyl-4-oxo-7-(1-piprazinyl)-4H-[1,3]thiazeto[3,2-a]quinoline-3-carboxylate

C18H20FN3O3S (377.1209342000001)

Fmoc-His-OH

C18H24BNO5S (377.14681640000003)

(4-(N-(tert-Butyl)-N-(4-methoxybenzyl)sulfamoyl)phenyl)boronic acid

N-Fmoc-2-amino-2-(2-propenyl)-4-Pentenoic acid

C19H15N5O4 (377.11239900000004)

4-[[2-methoxy-4-[(4-nitrophenyl)azo]phenyl]azo]phenol

4-Hydroxy-7-isopropyl-6-oxo-n-(3-(1-piperidinyl)propyl)-6,7-dihydrothieno(2,3-b)pyridine-5-carboxamide

C19H27N3O3S (377.1773032)

Pyridine, 4-(4-(4-fluorophenyl)-2-(5-((R)-methylsulfinyl)phenyl)-1H-imidazol-4-yl)-

Glufanide disodium

C16H17N3Na2O5 (377.0963552)

D006133 - Growth Substances > D043924 - Angiogenesis Modulating Agents D000970 - Antineoplastic Agents > D020533 - Angiogenesis Inhibitors D002317 - Cardiovascular Agents > D000889 - Anti-Arrhythmia Agents C274 - Antineoplastic Agent > C1742 - Angiogenesis Inhibitor D006133 - Growth Substances > D006131 - Growth Inhibitors D020011 - Protective Agents > D000931 - Antidotes C308 - Immunotherapeutic Agent D007155 - Immunologic Factors

3-((4-(2-(Dimethylamino)ethoxy)phenyl)methylene)-6-(phenylmethylene)-2,5-piperazinedione

Acridine half-mustard

C19H21Cl2N3O (377.1061596)

D000970 - Antineoplastic Agents > D018906 - Antineoplastic Agents, Alkylating > D009588 - Nitrogen Mustard Compounds D009676 - Noxae > D009153 - Mutagens

6-(4-Hydroxyphenyl)-5-(4-methoxyphenyl)-1,3-dimethylpyrrolo[3,4-d]pyrimidine-2,4-dione

C17H20ClN5O3 (377.1254600000001)

Dasolampanel

C78272 - Agent Affecting Nervous System > C47795 - CNS Stimulant

N-(2-methoxydibenzofuran-3-yl)-2-(4-methoxyphenoxy)acetamide

C18H20FN3O5 (377.13869220000004)

Ofloxacin N-oxide

D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D024841 - Fluoroquinolones

4-benzyl-N-[4-(difluoromethoxy)phenyl]piperazine-1-carbothioamide

C19H21F2N3OS (377.137332)

2-[2-Amino-5-(4-methoxyphenyl)-6-methylpyrimidin-4-yl]-5-[(2-methylprop-2-en-1-yl)oxy]phenol

5-benzoyl-6-methyl-4-[4-(4-morpholinyl)phenyl]-3,4-dihydro-1H-pyrimidin-2-one

Desethylclomifene

C24H24ClNO (377.1546324)

Diethylaminoethyl diphenylhydroxypropionate hydrochloride

7-Pyridin-2-Yl-N-(3,4,5-Trimethoxyphenyl)-7h-Pyrrolo[2,3-D]pyrimidin-2-Amine

(3s)-1-(1,3-Benzodioxol-5-Ylmethyl)-3-[4-(1h-Imidazol-1-Yl)phenoxy]piperidine

C21H13F2N3O2 (377.09757820000004)

[2-Amino-6-(2,6-difluoro-benzoyl)-imidazo[1,2-A]pyridin-3-YL]-phenyl-methanone

2-[(2-methoxyethyl)amino]-4-(4-oxo-1,2,3,4-tetrahydro-9H-carbazol-9-yl)benzamide

6-Carbamimidoyl-4-(3-hydroxy-2-methyl-benzoylamino)-naphthalene-2-carboxylic acid methyl ester

[4-({5-(Aminocarbonyl)-4-[(3-Methylphenyl)amino]pyrimidin-2-Yl}amino)phenyl]acetic Acid

Phentolamine mesylate

C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C72900 - Adrenergic Antagonist D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D018674 - Adrenergic Antagonists D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents Phentolamine mesylate (Phentolamine methanesulfonate) is a reversible, non-selective, and orally active blocker of α1 and α2 adrenergic receptor that expands blood vessels to reduce peripheral vascular resistance. Phentolamine mesylate can be used for the research of pheochromocytoma-related hypertension, heart failure and erectile dysfunction[1][2][3].

Naltrexone Hydrochloride

D002492 - Central Nervous System Depressants > D009294 - Narcotics > D053610 - Opiate Alkaloids COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D009292 - Narcotic Antagonists D002491 - Central Nervous System Agents > D000427 - Alcohol Deterrents C78272 - Agent Affecting Nervous System > C681 - Opiate Antagonist Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS

Lasmiditan

C19H18F3N3O2 (377.1351044)

Talarozole

Kinetin-7-N-glucoside

(2R,3R,4S,5S,6R)-2-(6-{[(furan-2-yl)methyl]amino}-7H-purin-7-yl)-6-(hydroxymethyl)oxane-3,4,5-triol

S-(4-oxobutan-2-yl)glutathione

Protuboxepin A

An organic heterotricyclic compound that is 10,11-dihydro-6H-oxepino[2,3-d]pyrazino[1,2-a]pyrimidine-6,9(8H)-dione substituted by a benzyl group at position 8 and a butan-2-yl group at position 11. It has been isolated from Aspergillus species.

N(2)-(5-phosphopyridoxyl)-L-lysine

C14H24N3O7P (377.1351804)

2-[(2-methyl-4-benzofuro[3,2-d]pyrimidinyl)thio]-N-(2-phenylethyl)acetamide

3-methoxy-N-[4-methyl-2-(4-morpholinyl)-6-quinolinyl]benzamide

C17H23N5O3S (377.15215280000007)

1-[(3,5-dimethyl-1H-pyrazol-4-yl)sulfonyl]-N-(5-methyl-2-pyridinyl)-4-piperidinecarboxamide

3,4-Dimethyl-6-(6-nitro-1,3-benzodioxol-5-yl)-2-oxo-1,6-dihydropyrimidine-5-carboxylic acid propyl ester

C17H19N3O7 (377.1222944)

1-[4-(3,4,5-Trimethoxyphenyl)-2-thiazolyl]-4-piperidinecarboxamide

Circumdatin J

(S)-talarozole

Glu-Asp-Asp

C20H19N5OS (377.13102440000006)

3-[(2-fluorophenyl)methyl]-5-propyl-N-(pyridin-4-ylmethyl)-7-triazolo[4,5-d]pyrimidinamine

C20H20FN7 (377.1764132)

4-allyl-1-anilino-6,7,8,9-tetrahydro[1]benzothieno[3,2-e][1,2,4]triazolo[4,3-a]pyrimidin-5(4H)-one

4-benzyl-N-(3,5-dichlorophenyl)-1,4-diazepane-1-carboxamide

C19H21Cl2N3O (377.1061596)

5-[(5-Tert-butyl-2,3-dimethylphenyl)sulfonylamino]-2-hydroxybenzoic acid

C19H23NO5S (377.12968680000006)

1-(2,5-Dimethoxyphenyl)-3-[5-(2-methylpiperidin-1-yl)-1,3,4-thiadiazol-2-yl]urea

C17H23N5O3S (377.15215280000007)

1-phenylspiro[1,3-diazinane-5,5-2,4,4a,6-tetrahydro-1H-[1,4]oxazino[4,3-a]quinoline]-2,4,6-trione

1-(2-Methoxyphenyl)-4-{[5-(4-methylphenyl)-3-isoxazolyl]carbonyl}piperazine

C17H15N9S (377.11710700000003)

N2-phenyl-6-[[(1-phenyl-5-tetrazolyl)thio]methyl]-1,3,5-triazine-2,4-diamine

3-(2,5-dioxo-1-pyrrolidinyl)-N-(2-methyl-1,3-dioxo-5-isoindolyl)benzamide

C20H15N3O5 (377.10116600000003)

1-(3-Chlorophenyl)-3-(9-cyclopentyl-9-azabicyclo[3.3.1]nonan-3-yl)thiourea

C20H28ClN3S (377.1692358000001)

2-cyano-N-(2-furanylmethyl)-2-[3-(4-morpholinyl)-2-quinoxalinyl]acetamide

C22H19NO3S (377.1085584000001)

N-ethyl-8-methyl-4-oxo-N-(phenylmethyl)-2-thieno[3,2-c][1]benzopyrancarboxamide

6-amino-5-cyano-2-(4-methoxyphenyl)-4-(3-pyridinyl)-4H-pyran-3-carboxylic acid ethyl ester

3-(4-methylphenyl)-5-oxo-N-propyl-8-thiazolo[2,3-b]quinazolinecarboxamide

5-ethyl-3-[(2-fluorophenyl)methyl]-N-[2-(2-pyridinyl)ethyl]-7-triazolo[4,5-d]pyrimidinamine

C20H20FN7 (377.1764132)

1-(3,4-dihydro-1H-isoquinolin-2-yl)-2-[(2-propyl-4-quinazolinyl)thio]ethanone

C15H18F3N3O3S (377.10209140000006)

2-[[2-Oxo-2-[4-[5-(trifluoromethyl)-2-pyridinyl]-1,4-diazepan-1-yl]ethyl]thio]acetic acid

N-methyl-N-(3-pyridinylmethyl)-5-(5,6,7,8-tetrahydronaphthalen-2-yloxymethyl)-3-isoxazolecarboxamide

(15S)-13-[(4-Fluorophenyl)methyl]-10,10-dimethyl-8,11,13-triazatetracyclo[7.7.0.02,7.011,15]hexadeca-1(9),2,4,6-tetraene-12,14-dione

(15S)-13-[(2-Fluorophenyl)methyl]-10,10-dimethyl-8,11,13-triazatetracyclo[7.7.0.02,7.011,15]hexadeca-1(9),2,4,6-tetraene-12,14-dione

(15R)-13-[(4-Fluorophenyl)methyl]-10,10-dimethyl-8,11,13-triazatetracyclo[7.7.0.02,7.011,15]hexadeca-1(9),2,4,6-tetraene-12,14-dione

(15S)-13-[(3-Fluorophenyl)methyl]-10,10-dimethyl-8,11,13-triazatetracyclo[7.7.0.02,7.011,15]hexadeca-1(9),2,4,6-tetraene-12,14-dione

(15R)-13-[(2-Fluorophenyl)methyl]-10,10-dimethyl-8,11,13-triazatetracyclo[7.7.0.02,7.011,15]hexadeca-1(9),2,4,6-tetraene-12,14-dione

Asp-Glu-Asp

Asn-Asn-Met

Leu-Met-Asp

Asp-Asp-Glu

Cysteinyl-glutaminyl-glutamine

Asp-Pro-Phe

Asp-Phe-Pro

Glu-Met-Val

Ile-Asp-Met

Met-Asn-Asn

Met-Leu-Asp

Thr-Glu-Glu

4-[(2E)-2-(2,4,5-trimethoxybenzylidene)hydrazinyl]-5H-pyrimido[5,4-b]indole

2-(3,5-dimethylphenoxy)acetic acid [3-(1H-benzimidazol-2-yl)-3-cyano-2-oxopropyl] ester

(1R,5S)-N-(1,3-benzodioxol-5-yl)-7-[4-[(E)-prop-1-enyl]phenyl]-3,6-diazabicyclo[3.1.1]heptane-6-carboxamide

(6R,7R,8S)-8-(hydroxymethyl)-7-[4-[(E)-prop-1-enyl]phenyl]-4-(pyridine-4-carbonyl)-1,4-diazabicyclo[4.2.0]octan-2-one

(6R,7S,8R)-8-(hydroxymethyl)-7-[4-[(E)-prop-1-enyl]phenyl]-4-(pyridine-4-carbonyl)-1,4-diazabicyclo[4.2.0]octan-2-one

(6S,7S,8R)-8-(hydroxymethyl)-7-[4-[(E)-prop-1-enyl]phenyl]-4-(pyridine-4-carbonyl)-1,4-diazabicyclo[4.2.0]octan-2-one

2-[[(1S,5R)-7-[4-(2-methoxyphenyl)phenyl]-3,6-diazabicyclo[3.1.1]heptan-3-yl]methyl]thiazole

(1S,5R)-N-(1,3-benzodioxol-5-yl)-7-[4-[(E)-prop-1-enyl]phenyl]-3,6-diazabicyclo[3.1.1]heptane-3-carboxamide

(6R,7R,8R)-8-(hydroxymethyl)-7-[4-[(E)-prop-1-enyl]phenyl]-4-(pyridine-4-carbonyl)-1,4-diazabicyclo[4.2.0]octan-2-one

(6R,7S,8S)-8-(hydroxymethyl)-7-[4-[(E)-prop-1-enyl]phenyl]-4-(pyridine-4-carbonyl)-1,4-diazabicyclo[4.2.0]octan-2-one

(6S,7S,8S)-8-(hydroxymethyl)-7-[4-[(E)-prop-1-enyl]phenyl]-4-(pyridine-4-carbonyl)-1,4-diazabicyclo[4.2.0]octan-2-one

(6S,7R,8R)-8-(hydroxymethyl)-7-[4-[(E)-prop-1-enyl]phenyl]-4-(pyridine-4-carbonyl)-1,4-diazabicyclo[4.2.0]octan-2-one

C18H21N2O5S- (377.11711160000004)

Propicillin(1-)

Asp-Met-Leu

Gln-Cys-Lys

Gln-Gln-Cys

Gln-Lys-Cys

Glu-Glu-Thr

Glu-Val-Met

Ile-Met-Asp

Lys-Cys-Gln

Lys-Gln-Cys

Met-Glu-Val

Met-Ile-Asp

Met-Pro-Met

Met-Val-Glu

Phe-Asp-Pro

Phe-Pro-Asp

Pro-Asp-Phe

Pro-Met-Met

Val-Glu-Met

Gln-Cys-Gln

Met-Asp-Ile

Asn-Met-Asn

Asp-Ile-Met

Asp-Leu-Met

Asp-Met-Ile

Cys-Gln-Lys

Cys-Lys-Gln

Glu-Thr-Glu

Leu-Asp-Met

Met-Asp-Leu

Met-Met-Pro

Pro-Phe-Asp

Val-Met-Glu

N-acetylmethionyltryptophan

C18H20ClN3O4 (377.1142270000001)

(2S)-2-[[(2-chlorophenyl)-oxomethyl]amino]-3-methylbutanoic acid (3-cyano-4-imino-2-oxopentyl) ester

ethyl 2-[(4E)-4-[[4-(dimethylamino)phenyl]methylidene]-5-oxo-1-phenylpyrazol-3-yl]acetate

(8aR)-2-(1-benzothiophen-2-ylmethyl)-7-benzyl-5,6,8,8a-tetrahydro-1H-imidazo[1,5-a]pyrazin-3-one

4,7-DI(Para-ethoxyphenyl)-1,2,5-thiadiazolo(3,4-C)pyridine

2-(2-Trimethylsilyloxyethoxy)-4-quinolinecarboxylic acid trimethylsilyl ester

C18H27NO4Si2 (377.1478542)

8-Amino-8-demethylriboflavin

Reduced haloperidol

3-[2-(4-Fluorophenyl)ethylamino]-1-methyl-4-(2-methyl-1H-indol-3-yl)pyrrole-2,5-dione

Cys-Gln-Gln

CBiPES

CBiPES is a potent mGlu2 positive allosteric modulator with an EC50 value of 92.8 nM. CBiPES attenuates stress-induced hyperthermia and Phencyclidine-induced hyperlocomotor activity. CBiPES can be used for research of neurological diseases[1][2].

CCT128930 (hydrochloride)

C18H21Cl2N5 (377.1173926)

CCT128930 hydrochloride is a potent and selective inhibitor of AKT (IC50=6 nM). CCT128930 hydrochloride has 28-fold selectivity over the closely related PKA kinase (IC50=168 nM) through the targeting of Met282 of AKT (Met173 of PKA-AKT chimera), as well as 20-fold selectivity over p70S6K (IC50=120 nM). CCT128930 hydrochloride induces cell cycle arrest, DNA damage, and autophagy. Antitumor activity[1][2].

Co 101244 (hydrochloride)

C21H16FN3O3 (377.11756379999997)

Co 101244 (PD 174494) hydrochloride is a NR2B-containing NMDA receptor antagonist[1].

H3R antagonist 1 (hydrochloride)

C19H24ClN3O3 (377.1506104)

H3R antagonist 1 hydrochloride is a histamine receptor 3 (H3R) inverse agonist extracted from patent WO2013107336A1, compound example 2.

mGluR2 antagonist 1

mGluR2 antagonist 1 is a highly potent, orally bioavailable and selective class of mGluR2 negative allosteric modulator (IC50 of 9 nM) with excellent brain permeability[1].

MLS-573151

MLS-573151 (MLS000573151) is a selective GTPase Cdc42 inhibitor with an EC50 of 2 μM. MLS-573151 is inactive against other GTPases family members, such as Rab2, Rab7, H-Ras, Rac1, Rac 2 and RhoA wild-type. MLS-573151 acts by blocking the binding of GTP to Cdc42[1][2].

n-{2-[5-(4-hydroxyphenyl)-1-methyl-4,8-dioxo-7h-pyrrolo[3,2-f]indol-3-yl]ethyl}-n-methylformamide

(23r)-12,13-dimethoxy-5,7-dioxa-19-azahexacyclo[15.7.0.0²,¹⁰.0⁴,⁸.0¹¹,¹⁶.0¹⁹,²³]tetracosa-1(17),2(10),3,8,11(16),12,14-heptaene

(1s,4r)-4-benzyl-3,10-dihydroxy-1-(sec-butyl)-1h,4h-pyrazino[2,1-b]quinazolin-6-one

(2s,3r,4r,5r,6s)-2-({6-[(z)-(hydroxyimino)methyl]-[2,2'-bipyridin]-3-yl}oxy)-6-methyloxane-3,4,5-triol

C17H19N3O7 (377.1222944)

2-[(23s)-24-methyl-5,7,18,20-tetraoxa-24-azahexacyclo[11.11.0.0²,¹⁰.0⁴,⁸.0¹⁴,²².0¹⁷,²¹]tetracosa-1(13),2,4(8),9,11,14,16,21-octaen-23-yl]ethanol

(1r,2r,3r,7s,8s,10r,15r,17r)-2,7-dihydroxy-8,10,17-trimethyl-6,14,18-trioxa-5-azapentacyclo[10.5.2.1⁴,⁷.0³,¹⁵.0¹⁵,¹⁹]icosa-4,12(19)-diene-11,13-dione

n-{3-[(2e)-n-{4-[(hydroxymethylidene)amino]butyl}-3-phenylprop-2-enamido]propyl}methylsulfanylcarboximidic acid

C19H27N3O3S (377.1773032)

2-hydroxy-4-(hydroxyimino)-7,9,16-trimethyl-13,17-dioxatetracyclo[9.5.2.0³,¹⁴.0¹⁴,¹⁸]octadec-11(18)-ene-6,10,12-trione

16-methoxycarbonyl-18,19-dihydroxynaufoline